Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
46.88
+0.17 (0.37%)
Sep 4, 2025, 1:07 PM - Market open
Qiagen Revenue
Qiagen had revenue of $533.54M in the quarter ending June 30, 2025, with 7.49% growth. This brings the company's revenue in the last twelve months to $2.04B, up 5.15% year-over-year. In the year 2024, Qiagen had annual revenue of $1.98B with 0.66% growth.
Revenue (ttm)
$2.04B
Revenue Growth
+5.15%
P/S Ratio
4.96
Revenue / Employee
$341,892
Employees
5,967
Market Cap
10.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
QGEN News
- 2 days ago - QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing - Business Wire
- 6 days ago - QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds - Business Wire
- 7 days ago - QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds - Business Wire
- 7 days ago - QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds - Business Wire
- 14 days ago - Qiagen: Diagnostics Vs. Life Sciences Pair Trade Analysis - Seeking Alpha
- 4 weeks ago - Qiagen N.V. (QGEN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability - Business Wire
- 6 weeks ago - QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - Business Wire